Ostersjöstiftelsen
9
3M
6
0.30
0.33
- Areas of investment
Summary
Ostersju00f6stiftelsen appeared to be the Corporate Investor, which was created in 1994. The main office of represented Corporate Investor is situated in the Huddinge. The venture was found in Europe in Sweden.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Software. For fund there is a match between the location of its establishment and the land of its numerous investments - Sweden. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Athera Biotechnologies, Dilafor, Modus Therapeutics.
The high activity for fund was in 2015. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Ostersju00f6stiftelsen, startups are often financed by Texas Venture Labs. The meaningful sponsors for the fund in investment in the same round are Rosetta Capital, Praktikerinvest, Midroc New Technology. In the next rounds fund is usually obtained by HealthCap.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Rounds per year
- 0.30
- Follow on index
- 0.33
- Investments by industry
- Pharmaceutical (7)
- Biotechnology (5)
- Health Care (3)
- Therapeutics (2)
- Software (1) Show 2 more
- Investments by region
-
- Sweden (9)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.89
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| OncoZenge | 16 Nov 2020 | Health Care, Pharmaceutical | Seed | 1M | Sodermanlands Lan, Bromma, Sweden |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.